Proteomics analysis of matched tumor and normal adjacent tumor regions of 40 patients with multiparametric magnetic resonance imaging (mpMRI) visible or invisible tumors. All patients have clinically significant intermediate-risk (pathological ISUP Grade Group 2), localized prostate cancer.
[doi:10.25345/C5T53T]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: Prostate cancer ; multiparametric magnetic resonance imaging ; radical prostatectomy ; mpMRI visibility ; proteogenomics ; gleason score ; multi-omics ; localized prostate cancer ; intermediate risk ; proteomics
Principal Investigators: (in alphabetical order) |
Dr. Thomas Kislinger, Princess Margaret Cancer Centre, Canada |
Submitting User: | TKislinger |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | |
FTP Download Link (click to copy):
|